Caris Life Sciences (CAI) Stock Price, Quote, News & History | Benzinga

Caris Life Sciences Inc (CAI) Stock Price, Quote, News & History

CAINASDAQ

Trade with Public

Trade with Public

$25.32

0.522.1%

Last update: Sep 3, 7:58 PM

$25.27

0.471.9%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$24.94

Close

$25.32

Volume / Avg.

6.43M / 4.16M

Day Range

$23.62 - $25.34

52 Wk Range

14.19 - 38.68

Market Cap

$7.14B

P/E Ratio

2.59

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

12.99%

Days to Cover

2.54

Recent Caris Life Sciences, Inc. News

Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. Energy leads, gold sinks 1.3% to $4,599.

Piero Cingari

Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today

Long-end Treasury yields snapped back toward 20-month highs; Walmart posted its worst session in four years.

Piero Cingari

Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.

Avi Kapoor

Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows

A selloff in high-flying chipmakers split Wall Street on Thursday, with Broadcom Inc. (NASDAQ:AVGO)‘s disappointing AI-revenue forecast testing the artificial-intelli

Piero Cingari

Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech

Stanley Druckenmiller cut Amazon, exited Alphabet while increasing bets on Argentina, commodities, semiconductors, biotech stocks during Q1.

Surbhi Jain

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

168.56M

Investing Cash Flow (TTM)

-144.72M

Financing Cash Flow (TTM)

-53.78M

Free Cash Flow (TTM)

123.96M

Capital Expenditure (TTM)

-44.60M

Net Change in Cash (TTM)

-29.94M

Analyst Trends and Forecast

3

May

0

0

0

0

Jun

2

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.67B

PE Ratio (TTM)

2.59

PE Ratio (FWD)

34.01

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.10

PB Ratio (TTM)

11.85

Earnings Yield % (TTM)

38.61%

Earnings Yield % (FWD)

2.94%

EV / EBITDA (TTM)

38.63

Price / EBITDA (TTM)

40.72

Price / Free Cash Flow (TTM)

56.72

Book Value / Share

$2.09

Company Debt

Total Debt

$393.15M

LT Debt

$392.97M

LT Debt Issuance (TTM)

$393.50M

LT Debt Repayment (TTM)

-$406.45M

Total Cash

$690.92M

Debt to Equity

0.76

Issuance of Debt (TTM)

-$12.95M

Repayment of Debt (TTM)

-$406.45M

Key Statistics

Open

$24.94

Close

$25.32

Volume / Avg.

6.43M / 4.16M

Day Range

$23.62 - $25.34

52 Wk Range

14.19 - 38.68

Market Cap

$7.14B

P/E Ratio

2.59

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

12.99%

Days to Cover

2.54

About

Sector

Health Care

Industry

Biotechnology

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algor...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Caris Life Sciences (CAI) stock?

A

You can purchase shares of Caris Life Sciences (NASDAQ:CAI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Caris Life Sciences (CAI) competitors?

A

Other companies in Caris Life Sciences’s space includes: Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), argenx SE (NASDAQ:ARGX), Moderna Inc (NASDAQ:MRNA) and BioNTech SE (NASDAQ:BNTX).

Q

What is the forecast, or price target, for Caris Life Sciences (CAI) stock?

A

Caris Life Sciences has a consensus price target of $28.92.

Q

What is the current price for Caris Life Sciences (CAI)?

A

The stock price for Caris Life Sciences (NASDAQ: CAI) is $25.27 last updated September 3, 2026 at 7:58 PM EDT.

Q

Does Caris Life Sciences (CAI) pay a dividend?

A

There are no upcoming dividends for Caris Life Sciences.

Q

When is Caris Life Sciences (NASDAQ:CAI) reporting earnings?

A

Caris Life Sciences does not have any upcoming earnings scheduled.

Q

Is Caris Life Sciences (CAI) going to split?

A

There is no upcoming split for Caris Life Sciences.

Q

What sector and industry does Caris Life Sciences (CAI) operate in?

A

Caris Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.